Series date: 
01/01/2019 - 6:00am EST to 12/31/2019 - 5:00pm EST

Disclosure Summary

Series Objectives:

This activity provides oncology teams a platform to discuss implementation of personalized medicine for cancer patients in a tumor board format which includes patient case discussions focused on complex genetic information, extensive tumor sequencing such as whole-exome and whole-genome sequencing.

Series Target Audience: 

Adult and Pediatric Hematology and Oncology physicians, surgeons, research, and biorepository team members 

Series Contacts:
Nurse Practitioner, Director of Cancer Research:  Julie Martin, DNP, julie.martin@prismahealth.org

Medical Director: Ki Chung, MD, ki.chung@prismahealth.org

Series location: 
ITOR Bright Conference Room – Cancer Institute
900 W. Faris Road
Greenville, SC 29605
United States

Sessions

Session Date
Oncology Molecular Tumor Board 04/09/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 05/14/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 06/11/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 07/09/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 08/13/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 09/10/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 10/08/2019 - 4:00pm to 5:00pm EDT
Oncology Molecular Tumor Board 11/12/2019 - 4:00pm to 5:00pm EST
Oncology Molecular Tumor Board 12/10/2019 - 4:00pm to 5:00pm EST